Local News: Cosby, TN 

 | 

Sign Up

 | 

Sign In

Anthrax News Editors

News Widget

Display the Anthrax news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Anthrax News

News on Anthrax continually updated from thousands of sources around the net.

Friday Feb 3 | Lake Cowichan Gazette

Fight back against those colds with effective weapons

It seems after the Christmas holiday with all those late nights, rich foods and probably way more sugar than usual, the infamous flu is back wreaking havoc on those taxed immune systems! So, I thought I would write an article on dealing with potent bacteria that are taking advantage of our neglectful ways.

Comment?

Related Topix: Medicine, Health

Thu Jan 26, 2012

PR-inside.com

Just Released: "Aradigm Corporation (ARDM) - Medical Equipment - Deals and Alliances Profile"

It has developed a pulmonary drug delivery platform, AERx, which can be customized for the delivery of drugs to the target along with liposomal formulations to work on this platform for preferential targeting of certain cell types.

Comment?

Related Topix: Biotech, Startups, Medicine, Aradigm, Medical Equipment, Healthcare Industry, Cystic Fibrosis, Health, Cipro, Ciprofloxacin (generic), Medication

Sat Dec 17, 2011

CiteULike

Drug Interactions with Bacillus anthracis Topoisomerase IV:...

The drugs most commonly used to treat anthrax are quinolones, which act by increasing the levels of DNA cleavage mediated by topoisomerase IV and gyrase.

Comment?

Related Topix: Medicine, Health, Cipro, Ciprofloxacin (generic), Medication

Wed Dec 14, 2011

KOB-TV

Albuquerque ranks lowest on U.S. Centers for Disease Control list

Albuquerque finds itself at the bottom of another one of those lists where you don't want to be at the bottom.

Comment?

Related Topix: Albuquerque, NM, Medicine, Health, Cipro, Ciprofloxacin (generic), Medication

Tue Dec 06, 2011

Freshnews

Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin ValortimA

PharmAthene, Inc. today announced that results from a Phase I clinical study of Valortim were published in the December issue of Clinical and Vaccine Immunology .

Comment?

Related Topix: Health, PharmAthene, Immunology, Biology, Science

Also on Topix